Zobrazeno 1 - 10
of 101
pro vyhledávání: '"Andrea Puig"'
Autor:
Simon Fifer, Jenni Godsell, Stephen Opat, Nada Hamad, Masa Lasica, Cecily Forsyth, Louisa Morand, Erica Smeaton, Sharon Winton, Andrea Puig, Marija McGeachie
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-15 (2024)
Abstract Background Listening to patient voices is critical, in terms of how people experience their condition as well as their treatment preferences. This research explored the patient journey, therapy attributes and goals among treatment experience
Externí odkaz:
https://doaj.org/article/393844fe1e9649d6889941648fb36c92
Autor:
Malcolm Hopwood, Elizabeth M. Scott, David Codyre, David Barton, Andrea Puig, Jarrad King, Gero Joks, Ian B. Hickie
Publikováno v:
Psychiatry Research Communications, Vol 4, Iss 3, Pp 100177- (2024)
Introduction: Esketamine has been approved in Australia and New Zealand as a third-line antidepressant treatment for treatment resistant depression. This study describes changes in quality of life, depressive symptoms and productivity in participants
Externí odkaz:
https://doaj.org/article/86676a3c0b4540e2bb8a9b26e7d8accb
Publikováno v:
Viruses, Vol 14, Iss 12, p 2717 (2022)
Bovine respiratory disease (BRD) is one of the most prevalent, deadly, and costly diseases in young cattle. BRD has been recognized as a multifactorial disease caused mainly by viruses (bovine herpesvirus, BVDV, parainfluenza-3 virus, respiratory syn
Externí odkaz:
https://doaj.org/article/8014cc884d2646ecb86310c9937e2688
Publikováno v:
Animals, Vol 12, Iss 19, p 2623 (2022)
Classically, the diagnosis of respiratory disease in cattle has been based on observation of clinical signs and the behavior of the animals, but this technique can be subjective, time-consuming and labor intensive. It also requires proper training of
Externí odkaz:
https://doaj.org/article/2188be0418cd42e6af5bad5aab1af1fd
Publikováno v:
Australasian Psychiatry. 31:76-81
Objective To examine patient characteristics, persistence and adherence to treatment associated with use of second-generation antipsychotic long-acting injectable (SGA LAI) medications in the Australian real-world setting. Method Five SGA LAIs were c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0100eced47a7e762c0dc285447470cb
https://doi.org/10.1177/10398562221142453
https://doi.org/10.1177/10398562221142453
Autor:
Stephen P. Mulligan, Stephen Opat, Chan Y. Cheah, Bryone Kuss, Mark Hertzberg, Paula Marlton, Sarah Poplar, Andrea Puig, Marija McGeachie, Robert Weinkove, Constantine S. Tam
Publikováno v:
Leukemia & Lymphoma. 64:312-318
Ibrutinib is a small molecule inhibitor of Bruton's tyrosine kinase indicated for the treatment of relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and mantle cell lymphoma (MCL). The Named Patient Progr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff027f2379a8b826fc932b9f913b2174
https://doi.org/10.1080/10428194.2022.2148220
https://doi.org/10.1080/10428194.2022.2148220
Autor:
Stephen P. Mulligan, Stephen Opat, Paula Marlton, Bryone Kuss, Poppy Gerungan, Andrea Puig, Marija McGeachie, Constantine S. Tam
Publikováno v:
British Journal of Haematology. 198:790-793
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33c6da38e9f2d85b714b643326186ad3
https://doi.org/10.1111/bjh.18306
https://doi.org/10.1111/bjh.18306
Publikováno v:
Patient preference and adherence. 16
Simon Fifer,1 Brittany Keen,1 Richard Newton,2 Andrea Puig,3 Marija McGeachie4 1Community and Patient Preference Research, Sydney, NSW, Australia; 2Monash University, Melbourne, VIC, Australia; 3Real World Evidence Department, Janssen-Cilag Australia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f81afcb552ad7cddf50468d71f50762c
https://pubmed.ncbi.nlm.nih.gov/35898923
https://pubmed.ncbi.nlm.nih.gov/35898923
Autor:
Tzu Hsiang Chien, Mahsa H Kouhkamari, Samuel Che, Thang Khuong, Tom Hsun-Wei Huang, Andrea Puig
Publikováno v:
Biologics : Targets & Therapy
Introduction Real-world treatment persistence to ustekinumab for Crohn’s disease (CD) was studied using Australian Pharmaceutical Benefits Scheme (PBS) data. Demographic and treatment pattern characteristics were also investigated. Methods Our retr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5d99e314837f00688b148606e11e751
https://doi.org/10.2147/btt.s310076
https://doi.org/10.2147/btt.s310076
Publikováno v:
El Trimestre Económico, Vol 73, Iss 290, Pp 407-418 (2006)
Externí odkaz:
https://doaj.org/article/262b55a7a5db4be99c81927501ae3de2